Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.88
Delayed Data
As of Apr 29
 -0.16 / -5.26%
Today’s Change
1.69
Today|||52-Week Range
6.69
+11.63%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.04
Today’s open3.03
Day’s range2.88 - 3.08
Volume292,577
Average volume (3 months)919,250
Market cap$65.1M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+15.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.02-4.20%
NVLSNivalis Therapeutics...-0.12-2.76%
REPHRecro Pharma Inc-0.04-0.58%
RNNRexahn Pharmaceutica...-0.00-1.15%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateMay 13, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs